September is Childhood Cancer Awareness Month. The most common type of childhood cancer is acute lymphocytic leukemia (ALL), a blood and bone marrow cancer that creates immature white blood cells that ...
Findings showed 42% of pediatric patients (22/53) achieved complete remission. The Food and Drug Administration (FDA) has approved Besponsa (inotuzumab ozogamicin) for the treatment of relapsed or ...
Obecabtagene autoleucel (obe-cel) is an autologous 41BB-ζ anti-CD19 chimeric antigen receptor (CAR) T-cell therapy which uses an intermediate-affinity CAR to reduce toxic effects and improve ...
At age 4, Jake Schilling was diagnosed with acute lymphocytic leukemia (ALL). It’s a blood cancer marked by the rapid and abnormal growth of lymphocytes — white blood cells that help fight infection ...
By Shreoshree Chakrabarty: B-Cell Acute Lymphoblastic Leukemia (B-ALL) is a rare but aggressive form of leukemia that primarily impacts adults, unlike its more common pediatric counterpart. It ...